Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.50 |
| ▸ | FABP7 | O15540 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5497604 | 0.91 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7132450 | 0.90 | KMT2A (0.54) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL12187737 | 0.88 | KMT2A (0.64) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL3623157 | 0.88 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL2194902 | 0.88 | KMT2A (0.53) | KMT2AFABP5FABP7CA1CA2 | |
| Hydrochloric Acid SCHEMBL18981946 | 0.87 | KMT2A (0.62) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL10261416 | 0.87 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL14759878 | 0.87 | KMT2A (0.60) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL5497609 | 0.85 | KMT2A (0.59) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7262938 | 0.85 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170246326-A1 | Modular Imaging Agents Containing Amino Acids and Peptides | ROCHESTER INSTITUTE OF TECHNOLOGY (US) | 2017-08-31 | — | — | US | disclosed |
| US-20160251378-A1 | Transmetalation Methods for the Synthesis of PET and SPECT Imaging Agents | ROCHESTER INSTITUTE OF TECHNOLOGY (US) | 2016-09-01 | — | — | US | disclosed |
| US-20030207400-A1 | Vectors for dna delivery | BIANCHI ELISABETTA (IT) | 2003-11-06 | — | — | US | disclosed |
| EP-1290198-A2 | VECTORS FOR DNA DELIVERY | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001088160-A2 | VECTORS FOR DNA DELIVERY | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI, S.P.A. (IT) | 2001-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160251378-A1 | Transmetalation Methods for the Synthesis of PET and SPECT Imaging Agents | SLC39A7, SLC39A14, SLC35A1 | KMT2A 1481/4885FABP5 2675/4885FABP7 286/4885 |
| US-20170246326-A1 | Modular Imaging Agents Containing Amino Acids and Peptides | SLC43A1, TAP1, TFIP11 | KMT2A 1561/4885FABP5 352/4885FABP7 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.